Latest Articles
How invisible symptoms and provider bias delay endometriosis diagnosis - Contemporary OB/GYN
How invisible symptoms and provider bias delay endometriosis diagnosis Contemporary OB/GYN
Published: Dec. 2, 2025, 2:02 p.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - Morningstar
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence Morningstar
Published: Dec. 2, 2025, 2 p.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - PR Newswire
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence PR Newswire
Published: Dec. 2, 2025, 2 p.m.
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia - Business Wire
Bayer Starts New Phase III Study with Mirena® for the Treatment of Nonatypical Endometrial Hyperplasia Business Wire
Published: Dec. 2, 2025, 1:05 p.m.
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia - Stock Titan
Bayer (BAYRY) starts SUNFLOWER Phase III Mirena trial for nonatypical endometrial hyperplasia Stock Titan
Published: Dec. 2, 2025, 1:05 p.m.
Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics - Femtech Insider
Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics Femtech Insider
Published: Dec. 2, 2025, 1:03 p.m.
Ziwig Publishes Validation Study for Saliva-Based Endometriosis Test - Femtech Insider
Ziwig Publishes Validation Study for Saliva-Based Endometriosis Test Femtech Insider
Published: Dec. 2, 2025, 11:38 a.m.
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence - PR Newswire UK
Ziwig Endotest®: Scientific Validation Published in NEJM Evidence PR Newswire UK
Published: Dec. 2, 2025, 9 a.m.
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts phase III study with Mirena for treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia - MarketScreener
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia MarketScreener
Published: Dec. 2, 2025, 7:36 a.m.
Link copied to clipboard!